SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001638599-19-000193
Filing Date
2019-02-07
Accepted
2019-02-07 16:42:57
Documents
1
Period of Report
2018-07-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc3a_5927.html 3/A  
1 PRIMARY DOCUMENT doc3a_5927.xml 3/A 2696
  Complete submission text file 0001638599-19-000193.txt   4030
Mailing Address 8748 TECHNOLOGY WAY RENO NV 89521
Business Address 8748 TECHNOLOGY WAY RENO NV 89521 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O EYENOVIA, INC. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017
Business Address
Rowe Michael M (Reporting) CIK: 0001744774 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-38365 | Film No.: 19575697